Monday, October 17, 2022 from 3:30 PM to 5:00 PM PDT at Imperial Ballroom B
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-176-L01-P
Activity Type: A Knowledge-Based Activity
Clinical pharmacists evaluate and manage patients with a variety of pulmonary conditions across both outpatient and inpatient settings. Chronic and acute pulmonary conditions can be monitored by various types of respiratory technological devices (e.g., mechanical ventilators, extracorporeal membrane oxygenation, in-check dial, digital spirometers, carbon monoxide monitors). The rise in respiratory devices can be attributed to various factors such as increases in the geriatric population and vaping, and as COVID-19 becomes endemic may have caused providers to utilize more technological advances to improve patient outcomes. It is imperative for clinical pharmacists to be educated on newer respiratory technology devices and their role in patient care to increase overall patient outcomes.
 | Moderator: Melissa Santibanez, Pharm.D., FCCM, BCCCP
Assistant Professor, Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida; Critical Care Pharmacist Faculty, Memorial Regional Hospital, Hollywood, Florida
View Biography |
Learning Objectives
1. Identify the appropriate use for each presented device in patients with select respiratory conditions.
2. Explain respiratory technology device data for therapeutic decision making.
3. Review the financial return on the implementation of respiratory technology devices.
4. Describe examples for pharmacist-driven services using respiratory technology devices.
5. Given a respiratory device, identify if its use is for diagnosis, therapeutics, and/or monitoring.